The Scripps Research Institute Scientists Turn Muscular Dystrophy Defect on and Off in Cells

Published: Jun 28, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

For the first time, scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified small molecules that allow for complete control over a genetic defect responsible for the most common adult onset form of muscular dystrophy. These small molecules will enable scientists to investigate potential new therapies and to study the long-term impact of the disease.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news